Blood test may spot hidden artery risk in dialysis patients
NCT ID NCT07179211
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looks at 120 adults on regular hemodialysis to see if a simple blood test called the neutrophil-to-lymphocyte ratio (NLR) can help detect peripheral artery disease (PAD). PAD is a common but often overlooked complication in kidney patients. The goal is to find a cheap, easy way to identify those at higher risk, so they can get help sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple, low-cost blood test to help identify hemodialysis patients at risk for peripheral artery disease, allowing for earlier monitoring and care.
- What could go wrong
- This is an observational study, not a treatment trial. It only looks for a link between a blood marker and disease, so it won't directly improve health. The results may not apply to all patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sohag faculty
Sohag, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Aging kidneys under the microscope: could a simple test predict failure?
- Could your gut bacteria hold the key to protecting your kidneys?
- Food as medicine: could cooking classes slow kidney disease?
- Could a phone app be the key to managing kidney disease?
- A new pill aims to slow kidney failure and save lives
- AI takes on kidney disease: a new model to forecast Who's at risk